GCM
AMPH icon

Graham Capital Management’s Amphastar Pharmaceuticals AMPH Stock Holding History

Graham Capital Management’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-20,288
Closed -$466K – 1228
2025
Q2 		$466K Sell
20,288
-6,136
-23% -$152K 0.01% 854
2025
Q1 		$766K Buy
+26,424
New +$844K 0.02% 637
2024
Q2 		– Sell
-6,339
Closed -$278K – 1027
2024
Q1 		$278K Buy
+6,339
New +$327K 0.01% 813
2022
Q3 		– Sell
-60,386
Closed -$2.1M – 1049
2022
Q2 		$2.1M Buy
60,386
+29,718
+97% +$1.06M 0.1% 196
2022
Q1 		$1.1M Buy
+30,668
New +$870K 0.05% 274

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return